TITLE

ONS NEUTROPENIA MANAGEMENT STATE OF THE KNOWLEDGE

AUTHOR(S)
Nirenberg, Anita; Davis, Arlene; Friese, Christopher; Gillespie, Theresa; Bush, Annette Parry; Rice, David
PUB. DATE
January 2007
SOURCE
Oncology Nursing Forum;Jan2007, Vol. 34 Issue 1, p198
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Neutropenia is a significant complication of chemotherapy which leads to morbidity and mortality, dose reductions and treatment delays. While much is known about the management of neutropenia, much remains unknown and many practices are not evidence-based. Neutropenia, a nursing sensitive patient outcome-designated symptom, is relevant to oncology nursing practice. Nurses contribute to assessment, patient education, symptom reporting, data collection/ monitoring and the prevention neutropenic complications. The ONS Neutropenia Special Interest Group requested direction in neutropenia management. In response, ONS formed a working group to develop the "State of the Knowledge on Neutropenia" (SOK-N). The project team identified experts to address prevention and management in both inpatient and community settings, clinical outcomes, risk management, infection and infection control, translational research, nursing education, research and health policy. Neutropenia literature, guidelines, meta-analyses, funded NIH and ONS studies were reviewed. The panel of experts participated in a symposium to present his/her respective areas of expertise. These presentations were recorded and transcribed in order to facilitate the preparation of a manuscript and workshops. The SOK-N symposium will result in a white paper to be published in the Oncology Nursing Forum and 10 regional workshops at local ONS chapters nationwide. The workshops will use lecture and audience participation formats and development of performance improvement projects for nurses to implement in their own practices. Neutropenia literature, guidelines, meta-analyses, funded NIH and ONS studies were reviewed. The panel of experts participated in a symposium to present his/her respective areas of expertise. These presentations were recorded and transcribed in order to facilitate the preparation of a manuscript and workshops. The SOK-N symposium will result in a white paper to be published in the Oncology Nursing Forum and 10 regional workshops at local ONS chapters nationwide. The workshops will use lecture and audience participation formats and development of performance improvement projects for nurses to implement in their own practices. Nurses play a critical role in the management of patients receiving combination chemotherapy. Assessment of risk factors prior to treatment and at each subsequent cycle, teaching patients signs and symptoms to monitor and report, documentation of patient care and outcomes all impact the quality of care patients receive. Maintaining relative chemotherapy dose intensity that may affect treatment outcomes, morbidity and mortality from treatment, patient and caregiver quality of life, and healthcare costs are within the nursing domain. This presentation will provide specific examples of risk assessment and patient monitoring tools which can be applied to oncology nursing practice to improve neutropenia management. Nursing research in the area of neutropenia assessment and management and future nursing research development will be addressed. Nurses play a critical role in the management of patients receiving combination chemotherapy. Assessment of risk factors prior to treatment and at each subsequent cycle, teaching patients signs and symptoms to monitor and report, and documentation of patient care and outcomes all impact the quality of care patients receive. Maintaining relative chemotherapy dose intensity that may affect treatment outcomes, morbidity and mortality from treatment, patient and caregiver quality of life, and healthcare costs are within the nursing domain. This presentation will provide specific examples of risk assessment and patient monitoring tools which can be applied to oncology nursing practice to improve neutropenia management. Nursing research in the area of neutropenia assessment and management and future nursing research development will be addressed. Funding Sources: David Rice is supported by a Doctoral Scholarship in Cancer Nursing from the American Cancer Society (DSCN-04-228-01)
ACCESSION #
83243914

 

Related Articles

  • Chemotherapy and Biotherapy Guidelines, and Recommendations for Practice 4th Edition. Wagner, Eileen; Elliot, Kristy; Enders, Wayne; Chobanuk, Janice; Tsui, Amanda // Canadian Oncology Nursing Journal;Fall2015, Vol. 25 Issue 4, p480 

    No abstract available.

  • Meeting nursing standards in chemotherapy administration education: One province's approach. O'Leary, Bernadine // Canadian Oncology Nursing Journal;Spring2015, Vol. 25 Issue 2, p215 

    The article discusses chemotherapy administration in Newfoundland and Labrador and need for preparing oncology nurses to meet the standards in chemotherapy administration education. Topics discussed include chemotherapy administration in Newfoundland and Labrador initiated by an oncology nurse...

  • Lung cancer: By the time it's detected, it may be too late. Greifzu, Sherry; Crebase, Cindy; Winnick, Barbara // RN;Mar87, Vol. 50 Issue 3, p52 

    Presents guidelines for nursing lung cancer patients. Signs and symptoms of lung cancer; Details of the patient assessment; Side effects common to chemotherapeutic agents. INSETS: What causes lung cancer;The signs and symptoms of metastasized cancer.

  • Partnering with oncology nursing leaders in Latin America to deliver an education program on oral therapies in cancer. Truant, Tracy; Green, Esther; Ayala de Calvo, Luz Esperanza // Canadian Oncology Nursing Journal;Fall2015, Vol. 25 Issue 4, p482 

    The article offers information on partnership with Latin American oncology nursing leaders to provide educational program on oral therapies (OT) in cancer. Topics discussed include Latin American nursing leaders with a Canadian working group, OT train-the-trainer program, and pilot workshop for...

  • Acute leukaemia: making sense of a complex blood cancer. Meenaghan, Teresa; Dowling, Maura; Kelly, Mary // British Journal of Nursing;1/26/2012, Vol. 21 Issue 2, p76 

    Acute leukaemia represents a diverse group of blood cancers that affect both children and adults. Treatment schedules for these haematology cancers are often prolonged, with many associated side effects and complications. Nurses caring for patients with acute leukaemia require an anticipatory...

  • Contemplating Neutropenic Management Issues at the Bedside.  // Oncology Nursing Forum;Mar/Apr2003 Supplement, Vol. 30, p69 

    Provides an overview of a podium session entitled Contemplating Neutropenic Management Issues at the Bedside, which will be presented at the 2003 Oncology Nursing Society 28th Annual Congress in Denver, Colorado. Moderator; Objectives; Topics to be discussed.

  • Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G-CSF therapies. Tonra, James R.; Lloyd, G. Kenneth; Mohanlal, Ramon; Huang, Lan // Cancer Chemotherapy & Pharmacology;Feb2020, Vol. 85 Issue 2, p461 

    Purpose: Chemotherapy-induced neutropenia (CIN) increases the risk of infections and mortality in cancer patients. G-CSF therapies are approved for the treatment of CIN, but non-G-CSF therapies are needed to increase efficacy and minimize side effects. Plinabulin is an inhibitor of...

  • @CNA. A member-driven advocacy success story. Mcnamee, Margot // Canadian Nurse;Feb2013, Vol. 109 Issue 2, p15 

    The article discusses Canadian Association of Nurses in Oncology (CANO) vision to develop national strategy for chemotherapy administration that will enable chemotherapy care from registered nurses.

  • PREVENTING INTRAPERITONEAL PORT (ABDOMINAL MEDIPORT) RELATED COMPLICATIONS: EFFICACY OF EVIDENCE-BASED TREATMENT GUIDELINES. Green, Robin; Downey, Andrea; McCaffrey, Kathleen; Fusco, Eileen; Muggia, Franco // Oncology Nursing Forum;Mar2006, Vol. 33 Issue 2, p434 

    Intraperitoneal (IP) chemotherapy is a concept based on pharmacologic principles and our knowledge of patterns of spread of certain cancers. Recent clinical trials have made it desirable to explore adjuvant consolidation IP therapy in those patients with peritoneal spread of disease following...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics